在UGIB预测死亡率和再接收:对Rockall,Glasgow-Blatchford和AIMS65分数进行比较研究
Mehdi Nasr Isfahani1, Masoud Fallah2, Peyman Adibi Sedeh3
1Department of Emergency Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. m_nasr54@med.mui.ac.ir.
BMC gastroenterology
|October 14, 2025
概括
前内镜Rockall评分 (pRS) 最好预测上部胃肠道出血 (UGIB) 患者的死亡率和再入院率. 这一分数有助于识别高风险个体,以便更好地应急管理和排放规划.
科学领域:
- 胃肠病学 胃肠病学
- 紧急医疗 紧急医疗
- 临床风险分层的临床风险分层
背景情况:
- 上部胃肠道出血 (UGIB) 是一个常见的紧急情况,需要准确的风险评估.
- 评估前内镜评分系统对于及时的患者管理至关重要.
研究的目的:
- 为了比较预先内镜前罗卡尔评分 (pRS),格拉斯哥-布拉奇福德评分 (GBS) 和AIMS65的30天死亡率和UGIB患者的再入院预测准确度.
- 评估这些评分系统在伊朗三级医院的实用性.
主要方法:
- 一项前性观察性研究,涉及290名成人UGIB患者.
- 在入学时使用pRS,GBS和AIMS65进行评估.
- 统计分析包括ROC曲线和AUC比较,以评估预后准确性.
主要成果:
- 前内镜Rockall评分 (pRS) 显示,死亡率 (AUROC=0.815) 和再入院率 (AUROC=0.605) 的预测准确度最高.
- 在低风险值的所有分数中观察到高灵敏度和NPV,pRS提供了最佳的预后平衡.
- 冲击,低心率,昏迷,精神状态变化和严重的并发症与不良结果有显著的联系.
结论:
- 前内镜Rockall评分 (pRS) 在识别高风险UGIB患者和指导早期治疗方面非常有效.
- pRS的强烈灵敏度和NPV支持其在紧急情况下用于排放规划和风险分层.
- 建议在不同的环境中进行进一步验证,以优化UGIB管理策略.
关键词:
30天死亡率30天死亡率我们的目标是AIMS6565应急部门的紧急情况.格拉斯哥 - 布拉奇福德比分得分在内镜前的rockall得分.预测得分系统的预测得分系统.再接纳是指重新接纳的人.风险分层是指风险的分层.三级转诊医院 三级转诊医院上部胃肠道出血 胃肠道上部出血更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.5K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.7K
相关概念视频
01:20Actuarial Approach
286
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
286
01:20Comparing the Survival Analysis of Two or More Groups
553
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
553
01:15Assumptions of Survival Analysis
392
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
392
01:24Kaplan-Meier Approach
574
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
574
01:21Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645